Qube Research & Technologies (QRT)
ETON icon

Qube Research & Technologies (QRT)’s Eton Pharmaceutcials ETON Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-34,557
Closed -$492K – 3687
2025
Q2 		$492K Sell
34,557
-52,291
-60% -$827K ﹤0.01% 2700
2025
Q1 		$1.13M Sell
86,848
-7,333
-8% -$111K ﹤0.01% 2204
2024
Q4 		$1.25M Buy
94,181
+61,839
+191% +$627K ﹤0.01% 2078
2024
Q3 		$194K Buy
32,342
+32,338
+808,450% +$137K ﹤0.01% 2594
2024
Q2 		$14 Sell
4
-44,610
-100% -$156K ﹤0.01% 3596
2024
Q1 		$167K Sell
44,614
-5,829
-12% -$25.5K ﹤0.01% 3106
2023
Q4 		$221K Buy
50,443
+45,686
+960% +$183K ﹤0.01% 2735
2023
Q3 		$19.8K Buy
+4,757
New +$18.4K ﹤0.01% 3148

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ETON Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Eton Pharmaceutcials (ETON) in Q3 2025, closing a stake of 34,557 shares — an estimated $492K sold.

Qube Research & Technologies (QRT) first reported a position in ETON in Q3 2023 and held it in 8 quarters. The position peaked at $1.25M in Q4 2024. 103 funds tracked by Wall St. Rank hold ETON as of Q3 2025.

  • Qube Research & Technologies (QRT) reported no remaining Eton Pharmaceutcials position as of Q3 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 34,557 Eton Pharmaceutcials shares in Q3 2025, an estimated $492K.
  • Qube Research & Technologies (QRT) first reported a position in Eton Pharmaceutcials in Q3 2023 and held it in 8 quarters.
  • Qube Research & Technologies (QRT)'s Eton Pharmaceutcials position peaked at $1.25M in Q4 2024.
  • 103 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.